Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P29
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthDecelerating
PeriodValue
2025-68.16%
2024-74.60%
202311.66%
2022219.04%
2021231.10%
2020-44.63%
2019-78.08%
20180.00%